TIDMCRDA

RNS Number : 7757L

Croda International PLC

31 December 2018

Croda International Plc ("Croda")

Acquisition of leading global vaccine adjuvant specialist

Further to the announcement on 17 December 2018, Croda has now completed the acquisition of Brenntag Biosector A/S ('Biosector') from Brenntag Nordic A/S on 28 December 2018. Biosector is a specialist in the manufacture and supply of adjuvants serving both the human and veterinary vaccine markets.

-ENDS-

For enquiries contact:

 
               Conleth Campbell, VP Investor Relations, 
 Investors:     Croda                                      +44 1405 860551 
 Press:        Charlie Armitstead, Teneo                   +44 7703 330269

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACQFKKDQDBDBDBN

(END) Dow Jones Newswires

December 31, 2018 02:00 ET (07:00 GMT)

Croda (LSE:CRDA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Croda Charts.
Croda (LSE:CRDA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Croda Charts.